Media contacts:
Sherry Baker, 404/377-1398, emoryheartnews@aol.com
Kathy Ovni Baker, 404/727-9371, kobaker@emory.edu
Janet Christenbury, 404/727-8599, jmchris@emory.edu
March 28, 2003


 



American College of Cardiology Annual Scientific Session Meeting in Chicago Features Emory Cardiologists and Researchers



CHICAGO ≠ What impact does depression have on the physical functioning of patients following coronary artery bypass surgery (CABG)? How did the dramatic treatment known as resynchronization therapy help 500 patients with severe congestive heart failure? Is there a new marker found in the blood that can help identify people with the earliest signs of atherosclerosis?



Does social support predict who will participate in cardiac rehabilitation after CABG? How do revascularization therapies for cardiogenic shock effect women differently than men? When is chest pain in women a sign of something ominous? And why are young women at increased risk of dying in the hospital following angioplasty, compared to men?

These are some of the topics Emory Heart Center physicians will be on hand to discuss at The American College of Cardiologyís (ACC) 52nd Annual Scientific Session. Considered by many heart specialists to be the most comprehensive cardiovascular educational event of the year, the ACCís 52nd Annual Scientific Session begins Sunday, March 30 and continues through Tuesday, April 1, in Chicago, Illinois. (Extramural programs will also be held on Saturday, March 29, and Wednesday, April 2.)

"The ACC Annual Scientific Session is always an exciting forum for sharing information on the latest advances in cardiovascular medicine and discussing clinical decision making skills," says Douglas Morris, M.D., Director of the Emory Heart Center. "Emory cardiologists and researchers welcome the opportunity to meet with our colleagues from all over the country and the world at this meeting."

Dr. Morris will accept the 2003 "Ongoing Commitment to the Promotion of Diversity and Cultural Enrichment in Medical Education Award" from the Association of Black Cardiologists on behalf of Emory University School of Medicine and David G. Harrison, MD, Director, Division of Cardiology at the ACC meeting. At a time when almost half of the cardiology training programs in the U.S. have never graduated an African American cardiologist, Emory's cardiology program has graduated approximately 20 heart specialists. The award will be presented at the Chicago Westin Hotel (Michigan Avenue) Cotillion Ballroom at 7pm on Sunday, March 29.

Dr. Morris will also present "New Biological Insights" on Tuesday, April 1, at 10:30 AM and "Approach to the Post-Bypass Patient: Arterial and Venous Conduits", the same day at 2:00 PM.

Additional Emory participation at the ACCís 52nd Annual Scientific Session will includes:
  • Emory cardiologist Nanette Kass Wenger, MD, Chief of Cardiology at Grady will preside over the program "Hormones, Endocrinology and Heart Disease " and present "Heart Disease in Women ≠ How Are We Doing in 2003"? (Saturday, March 29, 8:30 AM). Dr. Wenger will also be a participant in the session "Hormone Replacement Therapy: New, Not So New, but Relevant to Clinical Practice" ( Sunday, March 30, 5:30 ≠ 7:00 PM
  • "Social Support as a Predictor of Participation in Cardiac Rehabilitation After Coronary Artery Bypass Graft" presented by Liudmila N. Husak, M.D. (Sunday, March 30, 12:00 PM - 1:00 PM)
  • "Correlation of Peripheral Arterial Compliance and Framingham Coronary Heart Disease Risk Evaluation" presented by Warren W. Davis, MD (Monday, March 31, 1:00 PM - 2:00 PM)
  • "The Outcome of Percutaneous Coronary Interventions of Saphenous Vein Grafts in Diabetic Patients Compared to Nondiabetic Patients", presented by Salman Ashfaq, MD (Monday, March 31, 3:00 PM - 4:00 PM)
  • "Minimizing Ionizing Radiation: A New Alternative Method for Minimally Invasive Surgical Biventricular Resynchronization", presented by Omar M. Lattouf, MD (Monday, March 31, 3:00PM -5:00 pm)
  • "Clinical Improvement Seen in a Single Center Experience with Cardiac Resynchronization Therapy with Patients with Congestive Heart Failure: A Report of 500 Cases", presented by Jeff Greenberg, MD and Angel Leon, MD (Monday, March 31, 3:00 ≠ 5:00 PM).
  • "Resynchronization Does Not Change the Incidence of Ventricular Arrhythmias", a presentation by Angel R. Leon, MD., and other MIRACLE ICD (internal cardiac defibrillator) trial investigators at Emory Crawford Long Hospital's Carlyle Fraser Heart Center. (Monday, March 31, 4:15 PM - 4:30 PM).
  • "The Relationship of Oxidative Stress to Vascular Health in Humans", presented by Salman Ashfaq (Monday, March 31, 4:00 PM - 5:00 PM)
  • "Clinical Improvement Seen in a Single Center Experience With Cardiac Resynchronization Therapy in Patients With Congestive Heart Failure: A Report of 500 Cases", presented by Jeffrey M. Greenberg, MD. (Monday, March 31, 4:00 PM - 5:00 PM)
  • "The Relationship of Oxidative Stress to Vascular Health in Humans", a poster session presented by Salman Ashfaq (Monday, March 31, 4:00 PM - 5:00 PM)
  • "Resynchronization Does Not Change the Incidence of Ventricular Arrhythmias", a presentation by Angel R. Leon, MD., and other MIRACLE ICD (internal cardiac defibrillator) trial investigators at Emory Crawford Long Hospitalís Carlyle Fraser Heart Center. (Monday, March 31, 4:15 PM - 4:30 PM).
  • "Clinical Outcomes of Over 800 Radial Artery Grafts Used in Coronary Bypass Surgery", presented by Edward P. Chen, MD (Tuesday, April 1, 10:45 AM -11:00 AM)
  • "Redox State: A Novel Marker of Oxidative Stress, Correlates With Early Atherosclerosis in Humans", presented by Salman Ashfaq, MD (Tuesday, April 1, 11:45 AM -12:00 PM)
  • "Chest Pain in Women: Itís Either Benign or Something Really Bad", a panel chaired by Nanette Kass Wenger, MD (Tuesday, April 1, 12:15 p.m. ≠ 1:45 p.m.)
  • As part of a mini-course entitled "Psychosocial, Post-Traumatic Issues and Cardiovascular Disease" , Viola Vaccarino, MD, will present "Personality, Lifestyle and Depression as Cardiovascular Disease Risk Factors" at 2:00 PM and Christi Deaton, Ph.D., RN, F.A.H.A. will present "Heart Disease and the Family"( Sunday, March 29, 2:50 PM)
  • Christi Deaton, Ph.D., RN, F.A.H.A. will be a panel participant in "Measuring Health Status: Why Quality of Life is Important" (Tuesday, April 1, 12:15 ≠ 1:45 PM).
  • "Tripolar Pacing Reduces Left Ventricular Capture Threshold in Patients Having Biventricular Device Implantation" presented by Johnathan J. Langberg, MD (Tuesday, April 1, 4:00 PM - 4:15 PM)
  • John Puskas, MD, is presenting an invited talk on "Coronary Artery Bypass Surgery After Failed Percutaneous Intervention" ( Tuesday, April 1, 4:00PM -5:00 PM )
  • "Fit Versus Fat: Does It Matter What Patients Weigh", a symposium co-chaired by Nanette Kass Wenger, MD (Wednesday, April 2, 8:30AM. ≠ 10:00AM)
  • "Impact of Coronary Artery Bypass Graft Versus Percutaneous Coronary Intervention With Stent on Disease-Specific Functional Status in Diabetic and Nondiabetic Patients: Results From the SoS (Stent or Surgery)Trial", presented by William S. Weintraub, MD (Wednesday, April 2, 9:15 AM - 9:30 AM)
  • "C-Reactive Protein in Vascular Disease" co-chaired by Arshed A. Quyyumi, MD (Wednesday, April 2, 10:30 AM. - 12:00 PM)
  • "Effect of Gender According to Age on In-Hospital Mortality in Patients With Acute Myocardial Infarction in the ACC-National Cardiovascular Data Registry", presented by Sean C. Beinart, MD (Wednesday, April 2, 11:00 AM -11:15 AM).

    (Note: all times listed are Central time.)


 


Return to March Index





For more general information on The Robert W. Woodruff Health Sciences Center
call Health Sciences Communication's Office at 404-727-5686,
or send e-mail to hsnews@emory.edu





Copyright © Emory University, 2001. All Rights Reserved.